Literature DB >> 17513021

Novel Pd(II) complexes of 1-N-substituted 3-phenyl-2-pyrazoline derivatives and evaluation of antiamoebic activity.

Kakul Husain1, Mohammad Abid, Amir Azam.   

Abstract

Cyclization of Mannich base with N(4)-substituted thiosemicarbazides by different aliphatic, aromatic and cyclic amines afforded a series of new 1-N-substituted cyclised pyrazoline analogues of thiosemicarbazones (PYZ-TSC) 1-10. Reaction of [Pd(DMSO)(2)Cl(2)] with pyrazoline derivatives led to new palladium(II) complexes [Pd(PYZ-TSC)Cl(2)] 1a-10a. The structures of all the compounds were characterized by spectroscopic methods. It was concluded that the pyrazoline thiosemicarbazone derivatives have two chelating arms, one attached at the 2-position of the pyrazole ring (that is, N donor) and other (S donor) linked to the thiosemicarbazone branch. The determination of antiamoebic activity of all the compounds was done using HM1:IMSS strain of Entamoeba histolytica, among all the complexes, 8a showed the most promising IC(50)=0.37 microM vs. IC(50)=1.81 microM of metronidazole, the reference drug. MTT assay showed that the compounds are non-toxic to human kidney epithelial cell line.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17513021     DOI: 10.1016/j.ejmech.2007.03.021

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  8 in total

1.  3-(4-Chloro-phen-yl)-5-(thio-phen-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothio-amide.

Authors:  Hoong-Kun Fun; Thitipone Suwunwong; Suchada Chantrapromma
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-01-07

2.  5-(4-Meth-oxy-phen-yl)-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothio-amide.

Authors:  Phonpawee Nonthason; Thitipone Suwunwong; Suchada Chantrapromma; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-11-30

3.  5-(4-Eth-oxy-phen-yl)-3-(pyridin-2-yl)-4,5-dihydro-1H-pyrazole-1-carbothio-amide.

Authors:  Suchada Chantrapromma; Phonpawee Nonthason; Thitipone Suwunwong; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-02-24

4.  (E)-N'-Hy-droxy-1,3-diphenyl-4,5-di-hydro-1H-pyrazole-5-carboximidamide.

Authors:  N Srikantamurthy; K B Umesha; S Jeyaseelan; M Mahendra
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-05-05

5.  Synthesis, Structural Characterization, and Evaluation of the Biological Properties of Heteroleptic Palladium(II) Complexes.

Authors:  Hizbullah Khan; Nek Daraz; Muhammad Nasim Khan; Muhammad Said; Nosheen Akhtar; Amin Badshah; Amir Sada Khan; Murad Ali
Journal:  Bioinorg Chem Appl       Date:  2014-09-07       Impact factor: 7.778

Review 6.  Recent advances in the therapeutic applications of pyrazolines.

Authors:  Mohamed R Shaaban; Abdelrahman S Mayhoub; Ahmad M Farag
Journal:  Expert Opin Ther Pat       Date:  2012-03-08       Impact factor: 6.674

7.  1-{3-(4-Methyl-phen-yl)-5-[5-(2-nitro-phen-yl)furan-2-yl]-4,5-di-hydro-1H-pyrazol-1-yl}ethanone.

Authors:  N Vinutha; S Madan Kumar; B S Vidyashree Jois; Kalluraya Balakrishna; N K Lokanath; D Revannasiddaiah
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-09-12

8.  3-(4-Amino-phen-yl)-5-(4-meth-oxy-phen-yl)-4,5-di-hydro-1H-pyrazole-1-carbo-thio-amide.

Authors:  Thitipone Suwunwong; Suchada Chantrapromma; C S Chidan Kumar; Hoong-Kun Fun
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-07-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.